Endothelial BACE1 impairs insulin signaling to drive cerebral small vessel disease and stroke
Authors:
- Jianyu LiJLJianyu Li
- Tingting LinTLTingting Lin
- Zhenyu LongZLZhenyu Long
- Feng GaoFGFeng Gao
- Yong ShenYSYong Shen
Open Access
- 16 October 2026
- journal article
- Published by Elsevier in Science Bulletin
Abstract
No abstract availableKeywords
Funding Information
- Chinese Academy of Sciences
- National Natural Science Foundation of China
This publication has 58 references indexed in Scilit:
- Endothelial Nitric Oxide Synthase–Deficient MiceThe American Journal of Pathology, 2021
- Increased β‐site APP cleaving enzyme 1‐mediated insulin receptor cleavage in type 2 diabetes mellitus with cognitive impairmentAlzheimer's & Dementia, 2021
- The Y-Maze for Assessment of Spatial Working and Reference Memory in Mice2018
- P1‐040: ELENBECESTAT, A NOVEL BACE INHIBITOR, DEMONSTRATES SIMILAR PHARMACOKINETICS AND TOLERABILITY IN JAPANESE SUBJECTS WITH MULTIPLE DOSINGSAlzheimer's & Dementia, 2018
- The role of the nitric oxide pathway in brain injury and its treatment — From bench to bedsideExperimental Neurology, 2015
- P1‐335: Novel BACE1 inhibitor, E2609, lowers Aβ levels in the brain, cerebrospinal fluid and plasma in rats and guinea pigsAlzheimer's & Dementia, 2012
- P1‐336: Novel BACE1 inhibitor, E2609, lowers Aβ levels in the cerebrospinal fluid and plasma in nonhuman primatesAlzheimer's & Dementia, 2012
- O1‐06‐05: First‐in‐human study of E2609, a novel BACE1 inhibitor, demonstrates prolonged reductions in plasma beta‐amyloid levels after single dosingAlzheimer's & Dementia, 2012
- Blood-brain barrier and cerebral small vessel diseaseJournal of the Neurological Sciences, 2010
- Myelin basic protein: a multifunctional proteinCellular and Molecular Life Sciences, 2006